Results 201 to 210 of about 3,601 (217)

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

PHBV poly(3-hydroxybutyrate-co-3-hydroxyvalerate)

2016
openaire   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly  

Poly(ADP-ribose) polymerase inhibition: past, present and future

Nature Reviews Drug Discovery, 2020
Nicola J Curtin, Csaba Szabo
exaly  

Poly(aryl piperidinium) membranes and ionomers for hydroxide exchange membrane fuel cells

Nature Energy, 2019
Junhua Wang, Yun Zhao, Brian P Setzler
exaly  

New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

Nature Reviews Molecular Cell Biology, 2012
Bryan A Gibson, W Lee Kraus
exaly  

Poly(ionic liquid) composites

Chemical Society Reviews, 2020
Su-Yun Zhang, Hong Wang, Jian-Ke Sun
exaly  

Poly(ADP-ribose): novel functions for an old molecule

Nature Reviews Molecular Cell Biology, 2006
Valérie Schreiber, Françoise Dantzer
exaly  

Efficient, stable and scalable perovskite solar cells using poly(3-hexylthiophene)

Nature, 2019
Eui Hyuk Jung, Nam Joong Jeon, Tae Joo Shin   +2 more
exaly